메뉴 건너뛰기




Volumn 14, Issue 6, 2001, Pages 396-404

Initial clinical experience with interleukin-2 receptor antagonist induction in combination with tacrolimus, mycophenolate mofetil and steroids in simultaneous kidney-pancreas transplantation

Author keywords

Basilixmab; Daclizumab; Kidney pancreas transplantation; Outcome; Rejection

Indexed keywords

COTRIMOXAZOLE; GANCICLOVIR; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

EID: 0035664439     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001470100005     Document Type: Article
Times cited : (19)

References (26)
  • 5
    • 0033286618 scopus 로고    scopus 로고
    • Analysis of pancreas transplant outcomes for United States cases reported to the United Network for Organ Sharing (UNOS) and the non-US cases reported to the International Pancreas Transplant Registry (IPTR)
    • Cecka JM, Terasaki PI (eds). Los Angeles: UCLA Immunogenetics Center
    • (2000) Clinical Transplants 1999 , pp. 51-69
    • Gruessner, A.C.1    Sutherland, D.E.R.2
  • 12
    • 0033608073 scopus 로고    scopus 로고
    • Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody
    • United States Simulect Renal Study Group
    • (1999) Transplantation , vol.67 , pp. 276-284
    • Kahan, B.D.1    Rajagopalan, P.R.2    Hall, M.3
  • 22
    • 0030905149 scopus 로고    scopus 로고
    • Simultaneous use of tacrolimus and mycophenolate mofetil in combined pancreas-kidney transplant recipients: A multicenter report
    • (1997) Transplant Proc , vol.29 , pp. 654-655
    • Stratta, R.J.1
  • 26
    • 0002691890 scopus 로고    scopus 로고
    • Targeting the interleukin-2 receptor in clinical renal transplantation
    • (1999) Graft , vol.2 , pp. 56-61
    • Vincenti, F.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.